Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,134 | 53,393 | 62,977 | 16,062 | N/A |
| Marketable Securities | 1,706 | 1,825 | 1,766 | 1,806 | N/A |
| Receivables | 1,223 | 1,125 | 1,333 | 1,326 | N/A |
| Other current assets | 68 | 0 | 68 | 69 | 0 |
| TOTAL | $44,131 | $56,343 | $66,144 | $19,263 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 10,022 | 8,206 | 5,902 | 5,354 | N/A |
| TOTAL | $10,022 | $8,206 | $5,902 | $5,354 | $N/A |
| Total Assets | $54,153 | $64,549 | $72,046 | $24,617 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,357 | 5,747 | 3,323 | 3,016 | 0 |
| TOTAL | $5,357 | $5,747 | $3,323 | $3,016 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 17 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $17 | $N/A |
| Total Liabilities | $5,357 | $5,747 | $3,323 | $3,033 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 727 | 727 | 727 | 727 | N/A |
| Retained earnings | -100,521 | -98,281 | -80,568 | -73,270 | N/A |
| Other shareholders' equity | -378 | 0 | -378 | -378 | 0 |
| TOTAL | $48,796 | $58,802 | $68,723 | $21,584 | $N/A |
| Total Liabilities And Equity | $54,153 | $64,549 | $72,046 | $24,617 | $0 |